# The Copernicus Group IRB

The Copernicus Group IRB is an other based in Durham, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Durham, United States
- **Region:** North America
- **Address:** Durham, NC, United States
- **Assets under management:** Undisclosed

## Regulatory record

- **Reports private funds:** No

## About

The Copernicus Group IRB was founded in Durham, North Carolina, and serves as an independent institutional review board for clinical trials. Its core function is ethical oversight: reviewing study protocols, informed consent documents, and safety data to protect human subjects in biomedical research, a role mandated by the U.S. Department of Health and Human Services under 45 CFR 46. The firm focuses on the healthcare services sector, serving pharmaceutical, biotech, and medical device companies that outsource IRB review for operational efficiency and regulatory compliance. As an IRB organization, the Copernicus Group does not deploy capital or pursue investment returns. Its revenue derives from review fees charged to sponsors, and its operational footprint is concentrated in the United States, with Durham as the primary base. The firm handles a range of trial types, including multi-site studies and emergency-use protocols, but public information on the number of staff or active reviews is limited. The business model aligns with the broader trend of for-profit, centralized IRBs competing with academic and non-profit boards. The Copernicus Group lacks a disclosed founder, team size, or parent entity in public records as of mid-2026. It does not maintain a publicly accessible website, LinkedIn profile, or media presence beyond standard regulatory filings. This opacity is unusual for an IRB, which typically seeks visibility to reassure sponsors and regulators of its credentials. The firm's structural differentiator, if any, remains opaque due to sparse disclosure. Without a visible governance framework or published roster, its market position among IRBs — such as Western IRB, Advarra, or the WCG Group — cannot be assessed.

## Sectors

- Healthcare Services

## Questions

### How does The Copernicus Group IRB differ from academic IRBs?

The Copernicus Group is a for-profit, centralized IRB, unlike academic committees that are institution-based. Centralized IRBs review studies from multiple sponsors, offering faster turnaround and standardized processes. This model is increasingly used by pharmaceutical companies for multi-site trials, though critics note potential conflicts of interest in for-profit ethics review.

### What regulatory standards must The Copernicus Group IRB follow?

IRBs in the U.S. must comply with the Common Rule (45 CFR 46) and FDA regulations (21 CFR 50, 56). The Copernicus Group must register with the Department of Health and Human Services and adhere to Good Clinical Practice (GCP) guidelines. Enforcement is conducted by the FDA and the Office for Human Research Protections (OHRP).

## Related profiles

- [HC SemiTek Co.](https://altss.com/profile/hc-semitek-co)
- [TE Connectivity's Touch Solutions Business](https://altss.com/profile/te-connectivitys-touch-solutions-business)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/the-copernicus-group-irb

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology